A comparison between Chek 2 mutation carriers and non carriers in early breast cancer patients: A clinicopathological analysis

被引：0
|
作者：
Huszno, J. [1 ]
Budryk, M. [2 ,3 ]
Tecza, K. [2 ,4 ]
Pilat, J. Pamula [2 ,4 ]
Grzybowska, E. [2 ,4 ]
Kolosza, Z. [2 ,5 ,6 ]
Nowara, E. [1 ]
机构：
[1] Maria Sklodowska Curie Mem Inst Oncol, Clin & Expt Oncol Dept, Gliwice, Poland
[2] MSC Mem Canc Centere, Gliwice, Poland
[3] Inst Oncol, Gliwice Branch, Genet Outpationt Clin, Gliwice, Poland
[4] Inst Oncol, Gliwice Branch, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland
[5] Inst Oncol, Gliwice Branch, Dept Epidemiol, Gliwice, Poland
[6] Silesia Canc Registry, Gliwice, Poland
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30139-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
253
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [21] Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers
    Annegien Broeks
    Lot de Witte
    Anke Nooijen
    Angelina Huseinovic
    Jan G.M. Klijn
    Flora E. van Leeuwen
    Nicola S. Russell
    Laura J. van't Veer
    Breast Cancer Research and Treatment, 2004, 83 : 91 - 93
  • [22] Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers
    Borde, Julika
    Ernst, Corinna
    Wappenschmidt, Barbara
    Niederacher, Dieter
    Weber-Lassalle, Konstantin
    Schmidt, Gunnar
    Hauke, Jan
    Quante, Anne S.
    Weber-Lassalle, Nana
    Horvath, Judit
    Pohl-Rescigno, Esther
    Arnold, Norbert
    Rump, Andreas
    Gehrig, Andrea
    Hentschel, Julia
    Faust, Ulrike
    Dutrannoy, Veronique
    Meindl, Alfons
    Kuzyakova, Maria
    Wang-Gohrke, Shan
    Weber, Bernhard H. F.
    Sutter, Christian
    Volk, Alexander E.
    Giannakopoulou, Olga
    Lee, Andrew
    Engel, Christoph
    Schmidt, Marjanka K.
    Antoniou, Antonis C.
    Schmutzler, Rita K.
    Kuchenbaecker, Karoline
    Hahnen, Eric
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (07): : 893 - 899
  • [23] Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers
    Broeks, A
    de Witte, L
    Nooijen, A
    Huseinovic, A
    Klijn, JGM
    van Leeuwen, FE
    Russell, NS
    van't Veer, LJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (01) : 91 - 93
  • [24] Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
    Kriege, Mieke
    Jager, Agnes
    Hollestelle, Antoinette
    Berns, Els M. J. J.
    Blom, Jannet
    Meijer-van Gelder, Marion E.
    Sieuwerts, Anieta M.
    van den Ouweland, Ans
    Collee, J. Margriet
    Kroep, Judith R.
    Martens, John W. M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) : 1879 - 1887
  • [25] Early onset breast cancer: clinical characteristics and patterns of relapse in BRCA1/2 mutation carriers compared to non-carriers
    Fried, G.
    Matanis, E.
    Gershoni-Baruch, R.
    Dagan, E.
    BREAST, 2012, 21 : S19 - S20
  • [26] Analysis of Surgical Choice of Patients with Actionable Non-BRCA Carriers in Comparison to BRCA Gene Mutation Carriers
    Miller-Ocuin, Jennifer
    Chiba, Akiko
    Levine, Edward
    Howard-McNatt, Marissa
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S594 - S594
  • [27] Comparison of clinicopathological features and outcome of breast cancer in BRCA-mutation carriers, in patients with a family history without BRCA-mutation and in patients with sporadic disease
    Becourt, Stephanie
    Doucet, Ludovic
    Cohen-Haguenauer, Odile
    Ledoux, Florence
    Nguyen, Olivia
    Campedel, Luca
    Giacchetti, Sylvie
    Cuvier, Caroline
    Espie, Marc
    Teixeira, Luis
    CANCER RESEARCH, 2020, 80 (04)
  • [28] Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kengo Ikejima
    Sayuri Tokioka
    Kazuyo Yagishita
    Yuka Kajiura
    Naoki Kanomata
    Hideko Yamauchi
    Yasuyuki Kurihara
    Hiroko Tsunoda
    Journal of Medical Ultrasonics, 2023, 50 : 213 - 220
  • [29] Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study
    L Mellemkjær
    C Dahl
    J H Olsen
    L Bertelsen
    P Guldberg
    J Christensen
    A-L Børresen-Dale
    M Stovall
    B Langholz
    L Bernstein
    C F Lynch
    K E Malone
    R W Haile
    M Andersson
    D C Thomas
    P Concannon
    M Capanu
    J D Boice
    J L Bernstein
    British Journal of Cancer, 2008, 98 : 728 - 733
  • [30] Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
    Ikejima, Kengo
    Tokioka, Sayuri
    Yagishita, Kazuyo
    Kajiura, Yuka
    Kanomata, Naoki
    Yamauchi, Hideko
    Kurihara, Yasuyuki
    Tsunoda, Hiroko
    JOURNAL OF MEDICAL ULTRASONICS, 2023, 50 (02) : 213 - 220
12345